The Chinese NDRC imposes heavy fines on two pharmaceutical companies for monopoly pricing (Shuntong / Huaxin)

The NDRC has imposed fines of almost CNY 7 million, confiscated illegal gains, and imposed a cease-and-desist order on two pharmaceutical companies for monopoly pricing. The decision is the first

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Authors

  • University of Melbourne
  • China Competition Bulletin (Beijing)
  • Institute of American Studies (Beijing)

Quotation

Allan Fels, Xiaoye Wang, Jessica Su, The Chinese NDRC imposes heavy fines on two pharmaceutical companies for monopoly pricing (Shuntong / Huaxin), 15 November 2011, e-Competitions November 2011, Art. N° 74338

Visites 136

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues